Opinion: For African women at risk of HIV, a woke world is still sound asleep
The arrival in 2012 of a daily pill to prevent HIV infection was widely hailed as a breakthrough that could drive new infections worldwide to very low levels. Eight years later, it is having a strong impact in some places and little or none in others.
The real-world impact of pre-exposure prophylaxis, PrEP for short, certainly isn’t living up to its high expectations among young women in sub-Saharan Africa, who account for more than one-quarter of the 800,000 new HIV infections that occurred last year in the region.
